Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
13:04:25 EDT Sun 12 Oct 2025
Enter Symbol
or Name
USA
CA



Q:CYTK - CYTOKINETICS INC - https://www.cytokinetics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CYTK - Q0.258.01·61.890.560.04-0.27-0.41,313.977,66717,41260.27  60.50  58.5861.48  29.3119:17:54Sep 2915 min RT 2¢

Recent Trades - Last 10 of 17412
Time ETExPriceChangeVolume
19:17:54Q58.97-1.3470
19:06:48Q58.97-1.3435
18:14:18Q58.98-1.33100
18:14:08Q58.0544-2.2556170
18:13:59Q58.1237-2.1863170
18:13:58Q58.8662-1.4438100
18:13:51Q58.8663-1.443748
18:13:51Q58.8662-1.443852
18:13:35Q58.98-1.33100
18:13:27Q58.8663-1.4437100

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-09-29 07:31U:CYTKNews ReleaseCytokinetics Presents New Data Related to Aficamten at the HFSA Annual Scientific Meeting 2025
2025-09-24 07:30U:CYTKNews ReleaseCytokinetics Announces Call for Proposals for Its Eighth Annual Communications Grant Program
2025-09-23 16:00U:CYTKNews ReleaseCytokinetics to Present at the Stifel 2025 Virtual Cardiometabolic Forum
2025-09-18 16:00U:CYTKNews ReleaseCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
2025-09-18 07:30U:CYTKNews ReleaseCytokinetics Announces Three Upcoming Presentations at the HFSA Annual Scientific Meeting 2025
2025-09-16 23:46U:CYTKNews ReleaseCytokinetics Announces Pricing of Upsized $650.0 Million Convertible Senior Notes Offering; Refinances a Portion of 2027 Convertible Notes
2025-09-16 16:02U:CYTKNews ReleaseCytokinetics Announces Proposed Private Placement of $550.0 Million of Convertible Senior Notes
2025-08-31 12:10U:CYTKNews ReleaseCytokinetics Presents New Data Related to Aficamten at the European Society of Cardiology Congress 2025
2025-08-30 03:18U:CYTKNews ReleaseCytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine
2025-08-27 16:00U:CYTKNews ReleaseCytokinetics to Participate in September Investor Conferences
2025-08-25 07:30U:CYTKNews ReleaseCytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025
2025-08-20 07:30U:CYTKNews ReleaseCytokinetics Names Jim Daly to Board of Directors
2025-08-19 16:00U:CYTKNews ReleaseCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-08-07 16:00U:CYTKNews ReleaseCytokinetics Reports Second Quarter 2025 Financial Results and Provides Business Update
2025-07-24 16:00U:CYTKNews ReleaseCytokinetics to Announce Second Quarter Results On August 7, 2025
2025-07-18 16:00U:CYTKNews ReleaseCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
2025-07-10 07:30U:CYTKNews ReleaseCytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025
2025-06-17 16:00U:CYTKNews ReleaseCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-06-10 07:30U:CYTKNews ReleaseCytokinetics Announces Call For Proposals For Annual Corporate Giving Program
2025-05-29 16:01U:CYTKNews ReleaseCytokinetics to Participate in the Jefferies Global Healthcare Conference